Author:
Dewey R. A.,Morrissey G.,Cowsill C. M.,Stone D.,Bolognani F.,Dodd N.J.F.,Southgate T. D.,Klatzmann D.,Lassmann H.,Castro M.G.,Löwenstein P.R.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference45 articles.
1. Izquierdo, M. et al. Human malignant brain tumour response to herpes simplex tymidine kinase (HSVtk)/ganciclovir gene therapy. Gene Therapy 3, 491–495 (1996).
2. Ram, Z. et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Medicine 3, 1354–1361 (1997).
3. Klatzmann, D. et al. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Hum. Gene Ther. 9, 2595–2604 (1998).
4. Eck, S.L. et al. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. Hum. Gene Ther. 7, 1465–1482 (1996).
5. Freeman, S. et al. The "bystander effect": tumour regression when a fraction of the tumour mass is genetically modified. Cancer Res. 53, 5274–5283 (1993).
Cited by
289 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献